Purified anti-STAT2 Phospho (Tyr690) Antibody, STAT2 Phospho (Tyr690), W21151B,BioLegend,619851

Host

Mouse

Reactivity

Human

Application

WB - Quality tested

Platform ID

BAB211487846

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-STAT2 Phospho (Tyr690) Antibody, STAT2 Phospho (Tyr690), W21151B
Cat. No.619851
HostMouse
RRIDAB_3068194 (BioLegend Cat. No. 619851)AB_3068194 (BioLegend Cat. No. 619852)
IsotypeMouse IgG2a, κ
ReactivityHuman
ApplicationWB - Quality tested
ClonalityMonoclonal
Clone NumberW21151B
Concentration0.5 mg/mL
TargetSTAT2
ImmunogenSynthetic peptide from human STAT2 phosphorylated at Tyr690
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

STAT2 is a member of the STAT family of transcription factors that is phosphorylated by receptor associated kinases in response to cytokines and growth factors. After activation, STAT2 forms heterodimers with STAT1. Once it is activated, STAT1 and STAT2 dimerize and are translocated to the nucleus to act as a transcription factor. STAT2 is an important mediator of type I interferon signaling; thus, after type-I IFN binds to the receptor, JAK kinases phosphorylate STAT2 and STAT1. This leads to their dimerization and, together with IRF9/ISGF3G, form the ISGF3 transcription factor. Type-I IFN /STAT2 signaling is important in innate immunity antiviral responses. Additionally, STAT2 is a regulator of mitochondrial fission by modulating phosphorylation of DNM1L. Diseases associated with STAT2 are the Immunodeficiency 44 and Pseudo-Torch Syndrome 3.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.